Skip to main content

Published locations for Higher-risk MDS: Azacitidine plus pembrolizumab shows promise

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Higher-risk MDS: Azacitidine plus pembrolizumab shows promise

User login

  • Reset your password
  • /content/higher-risk-mds-azacitidine-plus-pembrolizumab-shows-promise
  • /hematology-oncology/article/235331/myelodysplastic-syndrome/higher-risk-mds-azacitidine-plus